The global renal biomarkers market was valued at USD 1044.64 Million in 2025 driven by the rising incidence of kidney diseases across the globe. The market is anticipated to grow at a CAGR of 7.65% during the forecast period 2026-2035 to reach a value of USD 2183.27 Million by 2035.
Base Year
Historical Period
Forecast Period
Continuous research and development activities to explore new biomarkers for renal conditions are driving the market growth.
The rising prevalence of chronic kidney diseases (CKD) is contributing to the increasing demand for novel treatments, propelling market demand.
The efforts of research institutes and promising discoveries are bringing hope to the renal biomarker domain, boosting market value in the forecast period.
Compound Annual Growth Rate
7.65%
Value in USD Million
2026-2035
*this image is indicative*
Biomarkers are used to perform diagnoses and prognoses of medical conditions to curate and develop effective treatments for the medical condition. Biomarkers can be lipids, proteins, microRNAs, proteomic patterns, genes, metabolites, or cells present on a urinalysis. Renal biomarkers are supposed to be used to enhance diagnosis and treatment approaches for renal diseases.
Rising Research Activities Poised to Bring Therapeutic Solutions
A new study published in May 2024 revealed that researchers discovered a novel biomarker in renal cell carcinoma subtypes. The cancer type is a diverse category with more than 20 known subtypes. The discovery is poised to enhance the ability to accurately diagnose many renal cell carcinoma subtypes, including some of the rarest subtypes. The enhanced diagnostic accuracy is expected to bring personalised treatments, improving patient outcomes. The discovery may trigger more researchers and key players to conduct additional research to explore more about the biomarker, anticipating market development.
Additionally, in January 2024, a group of researchers at MIT and Yale University School of Medicine discovered a compound originally developed as a potential cancer treatment that can allegedly treat autosomal dominant polycystic kidney disease (ADPKD). The drug exploits kidney cyst cells’ vulnerability to oxidative stress, a state of imbalance between damaging free radicals and beneficial antioxidants. The promising research is expected to bring innovative diagnostic approaches and treatments to the market, driving market growth. With a growing demand for biomarkers that can enable the development of targeted therapies and personalised treatments for patients, such research initiatives aimed at improving patient outcomes will propel market value in the coming years.
The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:
The EMR’s report titled “Global Renal Biomarkers Market Report and Forecast 2026-2035 offers a detailed analysis of the market based on the following segments:
Market Breakup by Biomarker Type
Market Breakup by Technique
Market Breakup by Application
Market Breakup by End Users
Market Breakup by Region
Segmentation by Biomarker Type to Witness Substantial Growth
Based on biomarker type, the market is divided into functional biomarker, up-regulated proteins and others. These biomarkers play a critical role in diagnosing, monitoring, and managing kidney-related diseases. The segment dominance can be attributed to the continuous discoveries of new markers that allegedly enhance diagnostic accuracy and prognostic capabilities. The high reliance of healthcare professionals on the combination of biomarkers to enhance patient outcomes drives demand for personalised treatments, reducing the burden of renal diseases.
Diagnostic Labs are Expected to Dominate the Market Share by End Users
The market segment by end users includes diagnostic labs, outpatient clinics, research centers, hospitals, and others. Diagnostic labs are leading the market segment due to the rising number of biomarkers testing that takes place at diagnostic labs. It offers a wide range of biomarker tests that are used to diagnose various aspects of kidney diseases, contributing to increased market demand. Their expertise in handling complex diagnostic procedures ensures accurate results and makes them the preferred choice for renal biomarker testing, propelling market growth.
Based on region, the market report covers North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Among these, North America dominates the market share due to the high prevalence of chronic kidney diseases (CKD) in the region. The CKD prevalence is probably high due to the rising incidence of other conditions such as diabetes and hypertension requiring effective, advanced diagnostic and monitoring tools. The presence of a robust healthcare infrastructure and the presence of prominent market players boost research, development, and innovation in the region, propelling market growth.
The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis and strategic initiatives by the leading players. The major companies in the market are as follows:
It is an American multinational company that develops and sells medical devices and healthcare products. The company is a global leader in diagnostic solutions and offers advanced laboratory systems and point-of-care testing products. Their diagnostics division includes immunoassays, clinical chemistry, hematology, and molecular diagnostics.
Copenhagen-based BioPorto is an in-vitro diagnostics company specializing in antibodies and assay development. The company is focused on developing compelling products to address unmet medical needs and tests that can help improve clinical and economic outcomes for patients, providers, and the healthcare ecosystem.
Commonly known as Roche, it is a Swiss multinational holding healthcare company operating in pharmaceuticals and diagnostics. It is the fifth-largest pharmaceutical company in the world by revenue specialising in providing treatments for cancer globally.
It is a German multinational company focused on providing innovative healthcare solutions through advanced technologies and services. The company offers a comprehensive range of diagnostic solutions, including clinical chemistry, immunoassays, hematology, and molecular diagnostics.
It is a life science and clinical research company. Thermo Fischer develops diagnostic tests and instruments that are used in clinical and industrial settings, like immunoassays, microbiology, and molecular diagnostics.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Q² Solutions Company, BioMerieux SA, Sphingotec GmbH, Enzo Life Sciences Inc., and Randox Laboratories Ltd.
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Biomarker Type |
|
| Breakup by Technique |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share